Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Cynthia Burman, Jamie Findlow, Helen S. Marshall & Marco A.P. Safadi. (2023) National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease. Expert Review of Vaccines 22:1, pages 839-848.
Read now
Read now
Katherine A. Hicks, Parinaz Ghaswalla, Justin Carrico, Seri Anderson, Patricia Novy, Cosmina Hogea & Mary S. Hayney. (2023) Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States. Journal of American College Health 0:0, pages 1-10.
Read now
Read now
Liping Huang, Sonya J. Snedecor, Paul Balmer & Amit Srivastava. (2022) Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States. Postgraduate Medicine 134:4, pages 341-348.
Read now
Read now
Anand P. Dubey, Rashna Dass Hazarika, Veronique Abitbol, Shafi Kolhapure & Someya Agrawal. (2022) Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Hassen Mohammed, Mark McMillan & Helen S. Marshall. (2022) Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Juliana de Oliveira Costa, Christopher Gianacas, Frank Beard, David Gonzalez-Chica, Kendal Chidwick, Rawa Osman, C. Raina MacIntyre & Alys Havard. (2021) Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019. Human Vaccines & Immunotherapeutics 17:10, pages 3692-3701.
Read now
Read now
Priya Pereira, Bernd Benninghoff & Leentje Moerman. (2020) Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines. Human Vaccines & Immunotherapeutics 16:11, pages 2861-2872.
Read now
Read now
Articles from other publishers (19)
David E. Bloom, Paolo Bonanni, Federico Martinón-Torres, Peter C. Richmond, Marco A. P. Safadi, David M. Salisbury, Apostolos Charos, Katharina Schley, Jamie Findlow & Paul Balmer. (2023) Meningococcal Disease in the Post–COVID-19 Era: A Time to Prepare. Infectious Diseases and Therapy.
Crossref
Crossref
L. S. Namazova-Baranova, O. A. Perminova, T. A. Romanova, V. V. Romanenko, A. N. Galustyan, V. N. Gorodin, I. V. OsipovaV. Yu. Rodnikova, S. M. Kharit, Yu. V. Kovshirina, V. А. Anokhin, S. B’Chir, D. Neveu, M. Bonaparte, G. Áñez, E. Jordanov, M. S. Dhingra & A. V. Goldstein. (2023) Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study. Epidemiology and Vaccinal Prevention 21:6, pages 65-81.
Crossref
Crossref
Ignacio Olivera, Carlos Grau, Luis Lazarov, Celia Martínez, Hugo Dibarboure, Juan Guillermo López, Cristian Oddo & Pablo Bianculli. (2023) Evolución e impacto presupuestario de posibles mejoras en el Programa de Inmunizaciones: Paraguay 2008-2020. Revista Latinoamericana de Infectología Pediátrica 36:3, pages 116-125.
Crossref
Crossref
Redouane Abouqal, Maher Beji, Mohamed Chakroun, Kamal Marhoum El Filali, Jihane Rammaoui & Hela Zaghden. (2022) Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Frontiers in Public Health 10.
Crossref
Crossref
Gyesi Razak Issahaku, Daniel Amobtiwon Amoatika, Donne Kofi Ameme, Delia Akosua Bandoh, Samuel Oko Sackey & Ernest Kenu. (2022) Imminent meningitis outbreak prevented by early warning and response action: Nadowli-Kaleo District, Upper West Region, Ghana-2017. Journal of Interventional Epidemiology and Public Health 5:2.
Crossref
Crossref
Giada Maria Di Pietro, Giulia Biffi, Massimo Luca Castellazzi, Claudia Tagliabue, Raffaella Pinzani, Samantha Bosis & Paola Giovanna Marchisio. (2022) Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention. International Journal of Environmental Research and Public Health 19:7, pages 4035.
Crossref
Crossref
Dorine Borensztajn, Nienke N Hagedoorn, Enitan Carrol, Ulrich von Both, Juan Emmanuel Dewez, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Jethro Herberg, Benno Kohlmaier, Michael Levin, Emma Lim, Ian Maconochie, Federico Martinon Torres, Ruud Nijman, Marko Pokorn, Irene Rivero-Calle, Maria Tsolia, Clementien Vermont, Dace Zavadska, Werner Zenz, Joany Zachariasse & Henriette A Moll. (2022) Characteristics and management of adolescents attending the ED with fever: a prospective multicentre study. BMJ Open 12:1, pages e053451.
Crossref
Crossref
Eylem Kiral & Ayse Filiz Yetimakman. (2021) Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit. Critical Care Research and Practice 2021, pages 1-4.
Crossref
Crossref
Eric Richardson, Kathleen A. Ryan, Robert M. Lawrence, Christopher A. Harle, Alyson Young, Melvin D. Livingston, Amit Rawal & Stephanie A. S. Staras. (2021) Perceptions and Knowledge About the MenB Vaccine Among Parents of High School Students. Journal of Community Health 46:4, pages 808-816.
Crossref
Crossref
I. Ya. Izvekova, L. V. Samoilova, L. Yu. Chernyshova, O. A. Simkina, T. Yu. Ivleva, E. I. Krasnova & U. A. Arkhipova. (2021) Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems. Epidemiology and Vaccinal Prevention 20:3, pages 60-75.
Crossref
Crossref
Nienke N Hagedoorn, Dorine Borensztajn, Ruud Gerard Nijman, Daan Nieboer, Jethro Adam Herberg, Anda Balode, Ulrich von Both, Enitan Carrol, Irini Eleftheriou, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Benno Kohlmaier, Emma Lim, Ian Maconochie, Federico Martinón-Torres, Marko Pokorn, Franc Strle, Maria Tsolia, Dace Zavadska, Werner Zenz, Michael Levin, Clementien Vermont & Henriette A Moll. (2021) Development and validation of a prediction model for invasive bacterial infections in febrile children at European Emergency Departments: MOFICHE, a prospective observational study. Archives of Disease in Childhood 106:7, pages 641-647.
Crossref
Crossref
Shamez N Ladhani, Ray Borrow & Mary E Ramsay. (2021) Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program. Clinical Infectious Diseases 73:1, pages e238-e240.
Crossref
Crossref
D. van der Vliet, T. Vesikari, B. Sandner, F. Martinón-Torres, G. Muzsay, A. Forsten, T. Adelt, C. Diaz Gonzalez, R. Simko, S. B'Chir, D. Neveu, E. Jordanov & M. S. Dhingra. (2021)
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT)
vs
. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
. Epidemiology and Infection 149.
Crossref
Crossref
Rachel Haimowitz, Rachel Torres, Susan Caleb, Danielle Thompson, Allison Smith, Carlo Ciotoli, Martha Dannenbaum & Linda Y. Fu. (2020) Serogroup B meningococcal vaccination practice patterns on college campuses. Vaccine 38:46, pages 7350-7356.
Crossref
Crossref
David Pace, Charmaine Gauci & Christopher Barbara. (2020) The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta. European Journal of Clinical Microbiology & Infectious Diseases 39:10, pages 1885-1897.
Crossref
Crossref
Mandeep S. Dhingra, James Peterson, James Hedrick, Judy Pan, David Neveu & Emilia Jordanov. (2020) Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study. Vaccine 38:33, pages 5194-5201.
Crossref
Crossref
Olof Säll, Emma Olofsson & Susanne Jacobsson. (2020) High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines. Vaccine 38:28, pages 4374-4378.
Crossref
Crossref
Lee-Jah Chang, James Hedrick, Shane Christensen, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States. Vaccine 38:19, pages 3560-3569.
Crossref
Crossref
Viviane Matos Ferreira, Ítalo Eustáquio Ferreira, How-Yi Chang, Amélia Maria Pithon Borges Nunes, Nadav Topaz, Ellen Reis Pimentel, Ana Rafaela Silva Simões Moura, Guilherme Sousa Ribeiro, Caroline Alves Feitosa, Mitermayer Galvão Reis, Xin Wang & Leila Carvalho Campos. (2020) Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil. Vaccine 38:14, pages 2995-3002.
Crossref
Crossref